Aryl sulfonamido tetralins based on lead compound 2a were synthesized and evaluated for Kv1. 5 inhibitory activity. Several compounds having IC50 values less then 0.1 μM were identified. Kv1. 5 inhibitors have the potential to be atrium-selective agents for the treatment of atrial fibrillation.